178 related articles for article (PubMed ID: 20558071)
1. Novel antimicrobial peptides that exhibit activity against select agents and other drug resistant bacteria.
Venugopal D; Klapper D; Srouji AH; Bhonsle JB; Borschel R; Mueller A; Russell AL; Williams BC; Hicks RP
Bioorg Med Chem; 2010 Jul; 18(14):5137-47. PubMed ID: 20558071
[TBL] [Abstract][Full Text] [Related]
2. De novo design of selective antibiotic peptides by incorporation of unnatural amino acids.
Hicks RP; Bhonsle JB; Venugopal D; Koser BW; Magill AJ
J Med Chem; 2007 Jun; 50(13):3026-36. PubMed ID: 17547385
[TBL] [Abstract][Full Text] [Related]
3. Design of perfectly symmetric Trp-rich peptides with potent and broad-spectrum antimicrobial activities.
Yang ST; Shin SY; Hahm KS; Kim JI
Int J Antimicrob Agents; 2006 Apr; 27(4):325-30. PubMed ID: 16563706
[TBL] [Abstract][Full Text] [Related]
4. Interaction of cationic antimicrobial peptides with phospholipid vesicles and their antibacterial activity.
Chou HT; Wen HW; Kuo TY; Lin CC; Chen WJ
Peptides; 2010 Oct; 31(10):1811-20. PubMed ID: 20600422
[TBL] [Abstract][Full Text] [Related]
5. Effects of Pro --> peptoid residue substitution on cell selectivity and mechanism of antibacterial action of tritrpticin-amide antimicrobial peptide.
Zhu WL; Lan H; Park Y; Yang ST; Kim JI; Park IS; You HJ; Lee JS; Park YS; Kim Y; Hahm KS; Shin SY
Biochemistry; 2006 Oct; 45(43):13007-17. PubMed ID: 17059217
[TBL] [Abstract][Full Text] [Related]
6. Bacterial membranes as predictors of antimicrobial potency.
Epand RM; Rotem S; Mor A; Berno B; Epand RF
J Am Chem Soc; 2008 Oct; 130(43):14346-52. PubMed ID: 18826221
[TBL] [Abstract][Full Text] [Related]
7. In vitro system for high-throughput screening of random peptide libraries for antimicrobial peptides that recognize bacterial membranes.
Xie Q; Matsunaga S; Wen Z; Niimi S; Kumano M; Sakakibara Y; Machida S
J Pept Sci; 2006 Oct; 12(10):643-52. PubMed ID: 16878349
[TBL] [Abstract][Full Text] [Related]
8. Application of unnatural amino acids to the de novo design of selective antibiotic peptides.
Hicks RP; Russell AL
Methods Mol Biol; 2012; 794():135-67. PubMed ID: 21956561
[TBL] [Abstract][Full Text] [Related]
9. The effect of the length and flexibility of the side chain of basic amino acids on the binding of antimicrobial peptides to zwitterionic and anionic membrane model systems.
Russell AL; Williams BC; Spuches A; Klapper D; Srouji AH; Hicks RP
Bioorg Med Chem; 2012 Mar; 20(5):1723-39. PubMed ID: 22304850
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.
Chou HT; Kuo TY; Chiang JC; Pei MJ; Yang WT; Yu HC; Lin SB; Chen WJ
Int J Antimicrob Agents; 2008 Aug; 32(2):130-8. PubMed ID: 18586467
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial peptides: new candidates in the fight against bacterial infections.
Toke O
Biopolymers; 2005; 80(6):717-35. PubMed ID: 15880793
[TBL] [Abstract][Full Text] [Related]
12. Determining the effect of the incorporation of unnatural amino acids into antimicrobial peptides on the interactions with zwitterionic and anionic membrane model systems.
Russell AL; Kennedy AM; Spuches AM; Gibson WS; Venugopal D; Klapper D; Srouji AH; Bhonsle JB; Hicks RP
Chem Phys Lipids; 2011 Nov; 164(8):740-58. PubMed ID: 21945566
[TBL] [Abstract][Full Text] [Related]
13. Bactericidal effect of bovine lactoferrin, LFcin, LFampin and LFchimera on antibiotic-resistant Staphylococcus aureus and Escherichia coli.
Flores-Villaseñor H; Canizalez-Román A; Reyes-Lopez M; Nazmi K; de la Garza M; Zazueta-Beltrán J; León-Sicairos N; Bolscher JG
Biometals; 2010 Jun; 23(3):569-78. PubMed ID: 20195887
[TBL] [Abstract][Full Text] [Related]
14. Effects of side group functionality and molecular weight on the activity of synthetic antimicrobial polypeptides.
Engler AC; Shukla A; Puranam S; Buss HG; Jreige N; Hammond PT
Biomacromolecules; 2011 May; 12(5):1666-74. PubMed ID: 21443181
[TBL] [Abstract][Full Text] [Related]
15. Synthetic diastereomeric-antimicrobial peptide: antibacterial activity against multiple drug resistant clinical isolates.
Park SC; Kim JY; Lee JK; Yoo S; Kim H; Seo CH; Nah JW; Hahm KS; Park Y
Biopolymers; 2011; 96(2):130-6. PubMed ID: 20564032
[TBL] [Abstract][Full Text] [Related]
16. Ceragenins: cholic acid-based mimics of antimicrobial peptides.
Lai XZ; Feng Y; Pollard J; Chin JN; Rybak MJ; Bucki R; Epand RF; Epand RM; Savage PB
Acc Chem Res; 2008 Oct; 41(10):1233-40. PubMed ID: 18616297
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity and mode of action of diastereomeric antimicrobial peptides against bacterial clinical isolates.
Pag U; Oedenkoven M; Papo N; Oren Z; Shai Y; Sahl HG
J Antimicrob Chemother; 2004 Feb; 53(2):230-9. PubMed ID: 14729742
[TBL] [Abstract][Full Text] [Related]
18. The effect of the placement and total charge of the basic amino acid clusters on antibacterial organism selectivity and potency.
Russell AL; Spuches AM; Williams BC; Venugopal D; Klapper D; Srouji AH; Hicks RP
Bioorg Med Chem; 2011 Dec; 19(23):7008-22. PubMed ID: 22047803
[TBL] [Abstract][Full Text] [Related]
19. Design of novel indolicidin-derived antimicrobial peptides with enhanced cell specificity and potent anti-inflammatory activity.
Nan YH; Bang JK; Shin SY
Peptides; 2009 May; 30(5):832-8. PubMed ID: 19428758
[TBL] [Abstract][Full Text] [Related]
20. A linguistic model for the rational design of antimicrobial peptides.
Loose C; Jensen K; Rigoutsos I; Stephanopoulos G
Nature; 2006 Oct; 443(7113):867-9. PubMed ID: 17051220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
